Sarepta Therapeutics (NASDAQ:SRPT) Now Covered by Scotiabank
Investment analysts at Scotiabank began coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) in a report issued on Friday,Benzinga reports. The brokerage set a “sector perform” rating and a $105.00 price target on the biotechnology company’s stock. Scotiabank’s price target points to a potential upside of 1.91% from the stock’s current price. […]
Investment analysts at Scotiabank began coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) in a report issued on Friday,Benzinga reports. The brokerage set a “sector perform” rating and a $105.00 price target on the biotechnology company’s stock. Scotiabank’s price target points to a potential upside of 1.91% from the stock’s current price. […]
